Persistent URL of this record https://hdl.handle.net/1887/95471
In Collections
This item can be found in the following collections:
The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trial
- All authors
- Huijbers, A.; Pelt, G.W. van; Kerr, R.S.; Johnstone, E.C.; Tollenaar, R.A.E.M.; Kerr, D.J.; Mesker, W.E.
- Date
- 2018-04-01
- Journal
- Journal of Surgical Oncology
- Volume
- 117
- Issue
- 5
- Pages
- 1043 - 1048